Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1.85%3.06B | 1.85%6.3B | 4.81%3B | -1.36%6.18B | -2.64%2.86B | 22.69%6.27B | 23.16%2.94B | 27.45%5.11B | 40.38%2.39B | 6.98%4.01B |
| Operating income | 1.85%3.06B | 1.85%6.3B | 4.81%3B | -1.36%6.18B | -2.64%2.86B | 22.69%6.27B | 23.16%2.94B | 27.45%5.11B | 40.38%2.39B | 6.98%4.01B |
| Cost of sales | -1.60%-2.44B | -0.62%-4.92B | -3.45%-2.4B | 2.50%-4.89B | 2.42%-2.32B | -22.48%-5.02B | -24.94%-2.37B | -25.26%-4.1B | -35.39%-1.9B | -9.66%-3.27B |
| Operating expenses | -1.60%-2.44B | -0.62%-4.92B | -3.45%-2.4B | 2.50%-4.89B | 2.42%-2.32B | -22.48%-5.02B | -24.94%-2.37B | -25.26%-4.1B | -35.39%-1.9B | -9.66%-3.27B |
| Gross profit | 2.85%619.83M | 6.51%1.38B | 10.58%602.66M | 3.22%1.29B | -3.55%545M | 23.56%1.25B | 16.20%565.05M | 37.17%1.01B | 64.00%486.26M | -3.49%738.3M |
| Selling expenses | 1.55%-115.2M | 2.26%-318.98M | 6.58%-117.01M | 11.60%-326.36M | -1.07%-125.25M | -17.22%-369.16M | 6.91%-123.93M | -32.62%-314.93M | -37.96%-133.13M | -10.14%-237.46M |
| Administrative expenses | -7.86%-328.38M | -4.85%-692.7M | -5.38%-304.45M | -7.35%-660.67M | 13.27%-288.91M | -21.70%-615.45M | -16.13%-333.12M | -9.29%-505.69M | -18.52%-286.85M | 0.02%-462.72M |
| Impairment and provision | ---- | ---6.14M | ---- | ---- | ---- | 68.70%-7.62M | ---- | 27.96%-24.35M | ---- | ---33.8M |
| -Other impairment is provision | ---- | ---6.14M | ---- | ---- | ---- | 68.70%-7.62M | ---- | 27.96%-24.35M | ---- | ---33.8M |
| Special items of operating profit | 114.16%31.65M | -82.76%14.87M | -74.60%14.78M | 511.95%86.25M | 341.26%58.17M | -47.51%14.1M | -17.59%13.18M | -11.47%26.86M | 521.72%16M | -9.27%30.34M |
| Operating profit | 6.08%207.89M | -4.63%372.69M | 3.69%195.98M | 43.05%390.79M | 55.96%189.01M | 40.38%273.18M | 47.29%121.19M | 461.54%194.6M | 279.58%82.28M | -71.13%34.66M |
| Financing income | -10.92%15.21M | -23.52%32.43M | -0.19%17.07M | 305.30%42.4M | 242.88%17.1M | -17.39%10.46M | -6.01%4.99M | 13.12%12.67M | -11.45%5.31M | -25.51%11.2M |
| Financing cost | 11.00%-57.48M | 6.02%-121.14M | -4.73%-64.58M | -143.97%-128.91M | -292.64%-61.67M | -92.06%-52.84M | -13.57%-15.71M | 35.92%-27.51M | 47.67%-13.83M | 22.50%-42.93M |
| Share of profits of associates | 216.82%257K | -1,421.64%-7.59M | 38.72%-220K | -137.62%-499K | -54.74%-359K | -158.66%-210K | -357.78%-232K | 102.23%358K | 103.03%90K | -672.14%-16.08M |
| Special items of earning before tax | ---- | ---- | ---7.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 17.60%165.88M | -9.02%276.39M | -2.10%141.05M | 31.74%303.79M | 30.70%144.08M | 28.03%230.59M | 49.28%110.24M | 1,469.27%180.11M | 206.67%73.85M | -116.95%-13.15M |
| Tax | -133.79%-30.95M | 50.70%-32.88M | 38.31%-13.24M | -171.40%-66.7M | -182.98%-21.46M | 1.40%-24.57M | -27.90%-7.58M | -1,024.22%-24.92M | -270.72%-5.93M | 91.41%-2.22M |
| After-tax profit from continuing operations | 5.57%134.93M | 2.70%243.51M | 4.23%127.81M | 15.09%237.1M | 19.45%122.62M | 32.75%206.02M | 51.15%102.66M | 1,109.63%155.19M | 203.29%67.92M | -129.68%-15.37M |
| Earning after tax | 5.57%134.93M | 2.70%243.51M | 4.23%127.81M | 15.09%237.1M | 19.45%122.62M | 32.75%206.02M | 51.15%102.66M | 1,109.63%155.19M | 203.29%67.92M | -129.68%-15.37M |
| Profit attributable to shareholders | 5.57%134.93M | 2.70%243.51M | 4.23%127.81M | 15.09%237.1M | 19.45%122.62M | 32.75%206.02M | 51.15%102.66M | 1,109.63%155.19M | 203.29%67.92M | -129.68%-15.37M |
| Basic earnings per share | 6.85%0.078 | 2.94%0.14 | 4.29%0.073 | 15.25%0.136 | 18.64%0.07 | 31.11%0.118 | 47.50%0.059 | 1,100.00%0.09 | 205.26%0.04 | -130.00%-0.009 |
| Diluted earnings per share | 6.85%0.078 | 2.94%0.14 | 4.29%0.073 | 15.25%0.136 | 20.69%0.07 | 31.11%0.118 | 48.72%0.058 | 1,100.00%0.09 | 202.63%0.039 | -130.00%-0.009 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.